APIC Offers Business Case for Infection Prevention Conference

Article

The Association for Professionals in Infection Control and Epidemiology (APIC) will hold its "Building an Effective Business Case for Infection Prevention" conference Sept. 12-13, 2010 in Baltimore, Md.

The Association for Professionals in Infection Control and Epidemiology (APIC) will hold its "Building an Effective Business Case for Infection Prevention" conference Sept. 12-13, 2010 at the Baltimore Waterfront Marriott in Baltimore, Md.

This interactive, hands-on workshop is designed specifically for experienced infection preventionists. Attendees will learn how to develop and use strategies, tools and templates to make a compelling business case for effective infection prevention and control programs, including how to convince healthcare administrators of the need for additional infection prevention resources.

Participants will learn how to:

-- Use and customize the APIC HAI Cost Calculator Tool to estimate the cost of infections in their own institution

-- Interpret the results of statistical models

-- Build a customized business case and effectively present it to healthcare administrative leadership

-- Create a compelling proposal to increase resources for infection prevention and control

-- Market accomplishments and demonstrate value

To register, CLICK HERE.

Related Videos
Picture at AORN’s International Surgical Conference & Expo 2024
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Infection Control Today Topic of the Month: Mental Health
Lucy S. Witt, MD, investigates hospital bed's role in C difficile transmission, emphasizing room interactions and infection prevention
Shelley Summerlin-Long, MPH, MSW, BSN, RN, senior quality improvement leader, infection prevention, UNC Medical Center, Chapel Hill, North Carolina
An eye instrument holding an intraocular lens for cataract surgery. How to clean and sterilize it appropriately? (Adobe Stock 417326809By Mohammed)
Christopher Reid, PhD (Photo courtesy of Christopher Reid, PhD)
Paper with words antimicrobial resistance (AMR) and glasses. (Adobe Stock 126570978 by Vitalii Vodolazskyi)
Association for the Health Care Environment (Logo used with permission)
Related Content
Paper with words Multidrug-resistant organism (MDO). (Adobe Stock 755358741 by MdBabul)

“It Takes a Village”: Preventing MDRO Spread Through Public Health Partnerships

April 19th 2024
Article

Tisha Mitsunaga, DrPH, ScM, discusses innovative approaches fostering collaboration between public health and healthcare facilities to combat multidrug-resistant organism (MDRO) spread.

Clostridioides difficile (Adobe Stock 260659307 by gaetan)

Navigating Clostridioides difficile Testing Guidelines: Addressing Adherence Challenges in Health Care Settings

April 18th 2024
Article

A study presented at the Society for Healthcare Epidemiology of America (SHEA) conference evaluated adherence to laxative administration guidelines before CDI testing in Veteran Affairs (VA) hospitals and explored associated demographic and contextual factors.

CDC on a laptop (Adobe Stock unknown)

CDC Strategies Preventing Hospital-Onset C difficile Effectiveness Inconclusive in Testing

April 15th 2024
Article

Hospitals using CDC prevention strategies had different incidences of hospital-associated Clostridioides difficile infection compared to those that didn't, but the reasons are not necessarily the strategies themselves.

AI in health care (Adobe Stock 588415732 by Suriyo)

Unlocking the Power of AI in Hospital Infection Prevention: A Sustainable Approach to HAIs

April 11th 2024
Article

Read on about how, as hospitals grapple with the costly burden of healthcare-associated infections (HAIs), artificial intelligence (AI) emerges as a game-changer in revolutionizing infection prevention strategies.

Infection Control Today's Infection Intel: Staying Ahead WIth Updates and Product Innovations.

Merck's V116 Vaccine Shows Promising Results in Phase 3 Studies at ISPPD: Key Findings and Real-World Impact

April 9th 2024
Article

Merck's V116, a 21-valent pneumococcal vaccine, exhibits strong immunogenicity and coverage in diverse adult populations. Real-world data reveal its potential to combat pneumococcal diseases effectively.

Carole W. Kamangu, MPH, RN, CIC, with Infection Control Today's Tori Whitacre Martonicz

Deeds to Reality: A Journey of Immigration and Obstacles With Carole W. Kamangu, MPH, RN, CIC

April 9th 2024
Article

Carole W. Kamangu, MPH, RN, CIC, shares her inspiring journey from the Democratic Republic of Congo to health care leadership in the US today. (This is the French translation of the interview with Carole W. Kamangu.)